Effects of Pay-For-Performance on Prescription of Hypertension Drugs among Public and Private Primary Care Providers in Sweden
(2018) In Working Papers- Abstract
- This study exploits policy reforms in Swedish primary care to examine the effect of pay-for-performance (P4P) on compliance with hypertension drug guidelines among public and private health care providers. Providers in regions with P4P are compared to providers in other regions in a difference-in-differences analysis using data from the Swedish Prescription Register for the period 2005-2013. The results indicate that P4P improved guideline compliance regarding prescription of Angiotensin Converting Enzyme (ACE) inhibitors and Angiotensin Receptor Blockers (ARB). The effect is mainly driven by private providers, suggesting that policy makers should take ownership into account when designing incentives for health care providers.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/0c22d60a-19fd-424d-bc6f-d7d27919b57c
- author
- Ellegård, Lina Maria LU
- organization
- publishing date
- 2018
- type
- Working paper/Preprint
- publication status
- published
- subject
- keywords
- Pay-for-performance, Hypertension treatment, Ownership, Primary health care, D23, H73, I11, I18, J33
- in
- Working Papers
- issue
- 2018:6
- pages
- 25 pages
- project
- Public Management Research
- language
- English
- LU publication?
- yes
- id
- 0c22d60a-19fd-424d-bc6f-d7d27919b57c
- date added to LUP
- 2018-03-28 09:33:47
- date last changed
- 2024-09-10 00:13:52
@misc{0c22d60a-19fd-424d-bc6f-d7d27919b57c, abstract = {{This study exploits policy reforms in Swedish primary care to examine the effect of pay-for-performance (P4P) on compliance with hypertension drug guidelines among public and private health care providers. Providers in regions with P4P are compared to providers in other regions in a difference-in-differences analysis using data from the Swedish Prescription Register for the period 2005-2013. The results indicate that P4P improved guideline compliance regarding prescription of Angiotensin Converting Enzyme (ACE) inhibitors and Angiotensin Receptor Blockers (ARB). The effect is mainly driven by private providers, suggesting that policy makers should take ownership into account when designing incentives for health care providers.}}, author = {{Ellegård, Lina Maria}}, keywords = {{Pay-for-performance; Hypertension treatment; Ownership; Primary health care; D23; H73; I11; I18; J33}}, language = {{eng}}, note = {{Working Paper}}, number = {{2018:6}}, series = {{Working Papers}}, title = {{Effects of Pay-For-Performance on Prescription of Hypertension Drugs among Public and Private Primary Care Providers in Sweden}}, url = {{https://lup.lub.lu.se/search/files/194851925/WP18_6.pdf}}, year = {{2018}}, }